节点文献
磺胺类碳酸酐酶抑制剂研究进展
Advance in sulfonamides as carbonic anhydrase inhibitors
【摘要】 碳酸酐酶抑制剂(CAIs)作为药物具有广泛的生物活性,如抗青光眼、利尿、抗肿瘤、抗癫痫、抗风湿、降血糖等。近几年,新一代抗青光眼磺胺类CAIs已经取得很大的研究成果,抗肿瘤磺胺类CAIs的研究也日益活跃,发展极为迅速。现综述磺胺类CAIs在抗青光眼和抗肿瘤领域的研究进展。
【Abstract】 Carbonic anhydrase inhibitors(CAIs) as drugs display extensively biologic activities such as antiglaucomatous,diuretic,antitumor,antiepileptic,antiarthritic,hypoglycemic ones.In recent years,the new generation of sulfonamides-type CAIs used for antiglaucoma have gained a lot of achievements.Much work is being focused on sulfonamide-type CAIs as antitumor drugs,the research is increasingly active,and the progress is very quick.This paper reviewed the recent advance of sulfonamide-type CAIs in antiglaucoma and antitumor field.
【关键词】 磺胺;
碳酸酐酶抑制剂;
抗青光眼;
抗肿瘤;
【Key words】 sulfonamide; carbonic anhydrase inhibitor; antiglaucoma; antitumor;
【Key words】 sulfonamide; carbonic anhydrase inhibitor; antiglaucoma; antitumor;
【基金】 国家人事部重点项目(2002-99);教育部留学回国人员启动金(2004-527);重庆市科委项目(2005BB5102);西南大学人才引进基金(SWUB2006018);西南大学高新技术培养基金(XSGX0602)
- 【文献出处】 中国新药杂志 ,Chinese Journal of New Drugs , 编辑部邮箱 ,2007年18期
- 【分类号】R98
- 【被引频次】47
- 【下载频次】1008